Claudin-1 as a novel target gene induced in obesity and associated to inflammation, fibrosis and cell differentiation.

Obesity claudin immunometabolism lymphocytes

Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
20 Feb 2024
Historique:
received: 07 09 2023
revised: 26 01 2024
accepted: 06 02 2024
medline: 20 2 2024
pubmed: 20 2 2024
entrez: 20 2 2024
Statut: aheadofprint

Résumé

T-lymphocytes from visceral and subcutaneous white adipose tissue (vWAT and sWAT, respectively) can have opposing roles in the systemic metabolic changes associated with obesity. However, few studies have focused on this subject. Claudin-1 (CLDN1) is a protein involved canonically in Tight Junctions (TJs) and tissue paracellular permeability.We evaluated T lymphocytes gene expression in vWAT and sWAT and in the whole adipose depots in human samples. A Clariom D-based transcriptomics analysis was performed on T lymphocytes magnetically separated from vWAT and sWAT from patients with obesity (Cohort 1; N = 11). Expression of candidate genes resulting from that analysis was determined in whole WAT from individuals with and without obesity (Cohort 2; Patients with obesity: N = 13; Patients without obesity: N=14). We observed transcriptional differences between T lymphocytes from sWAT compared to vWAT. Specifically, CLDN1 expression was found to be dramatically induced in vWAT T cells relative to those isolated from sWAT in patients with obesity. CLDN1 was also induced in obesity in vWAT and its expression correlates with genes involved in inflammation, fibrosis and adipogenesis. These results suggest CLDN1 is a novel marker induced in obesity, and differentially expressed in T lymphocytes infiltrated in human vWAT as compared to sWAT. This protein may have a crucial role in the crosstalk between T lymphocytes and other adipose tissue cells and may contribute to inflammation, fibrosis and alter homeostasis and promote metabolic disease in obesity.

Identifiants

pubmed: 38375549
pii: 7610964
doi: 10.1093/ejendo/lvae018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of European Society of Endocrinology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Pablo Fernández-García (P)

Department of Basic Health Sciences, Campus Alcorcón, University Rey Juan Carlos (URJC), E-28922 Madrid, Spain.

Siri D Taxerås (SD)

Fundació Institut Germans Trias i Pujol, Barcelona, 08916, Spain.

Marjorie Reyes-Farias (M)

Fundació Institut Germans Trias i Pujol, Barcelona, 08916, Spain.
Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain.

Lorena González (L)

Fundació Institut Germans Trias i Pujol, Barcelona, 08916, Spain.

Andrea Soria-Gondek (A)

Pediatric Surgery Department, Hospital Universitari Germans Trias i Pujol, Badalona, 08916, Spain.

Silvia Pellitero (S)

Endocrinology Department, Hospital Universitari Germans Trias i Pujol, Badalona, 08916, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERDEM), Madrid, 28029, Spain.

Jordi Tarascó (J)

General Surgery Department, Hospital Universitari Germans Trias i Pujol, Badalona, 08916, Spain.

Pau Moreno (P)

General Surgery Department, Hospital Universitari Germans Trias i Pujol, Badalona, 08916, Spain.

Lauro Sumoy (L)

Fundació Institut Germans Trias i Pujol, Barcelona, 08916, Spain.

Jacqueline M Stephens (JM)

Pennington Biomedical Research Center (PBRC) and Louisiana State University. Baton Rouge Louisiana, USA. 70808.

Lindsey G Yoo (LG)

Pennington Biomedical Research Center (PBRC) and Louisiana State University. Baton Rouge Louisiana, USA. 70808.

María Galán (M)

Department of Basic Health Sciences, Campus Alcorcón, University Rey Juan Carlos (URJC), E-28922 Madrid, Spain.

Adriana Izquierdo (A)

Department of Basic Health Sciences, Campus Alcorcón, University Rey Juan Carlos (URJC), E-28922 Madrid, Spain.

Gema Medina-Gómez (G)

Department of Basic Health Sciences, Campus Alcorcón, University Rey Juan Carlos (URJC), E-28922 Madrid, Spain.

Laura Herrero (L)

Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain.

Patricia Corrales (P)

Department of Basic Health Sciences, Campus Alcorcón, University Rey Juan Carlos (URJC), E-28922 Madrid, Spain.

Francesc Villarroya (F)

Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain.
Department of Biochemistry and Molecular Biomedicine, and Institute of Biomedicine, University of Barcelona, Barcelona, Spain.

Rubén Cereijo (R)

Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain.
Department of Biochemistry and Molecular Biomedicine, and Institute of Biomedicine, University of Barcelona, Barcelona, Spain.
Institut de Recerca Hospital de la Santa Creu i Sant Pau, Barcelona, 08041, Spain.

David Sánchez-Infantes (D)

Department of Basic Health Sciences, Campus Alcorcón, University Rey Juan Carlos (URJC), E-28922 Madrid, Spain.
Fundació Institut Germans Trias i Pujol, Barcelona, 08916, Spain.
Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain.

Classifications MeSH